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We performed a prospective, double-blinded study in 20 patients undergoing gynecologic surgery with lower abdominal incision,
to investigate characteristics of intrathecal hyperbaric levobupivacaine compared with isobaric levobupivacaine. We randomly
assigned them to receive 3mL of either isobaric or hyperbaric 0.42% levobupivacaine intrathecally. We found that hyperbaric
levobupivacaine, compared with isobaric levobupivacaine, spread faster to T10 level (2.8 ± 1.1 versus 6.6 ± 4.7 minutes, P =
0.039), reached higher sensory block levels at 5 and 15 minutes after injection (T8 versus L1, P = 0.011, and T4 versus T7,
P = 0.027, resp.), and had a higher peak level (T4 versus T8, P = 0.040). Isobaric levobupivacaine caused a wider range of peak
levels (L1 to C8) compared with hyperbaric form (T7 to T2). The level of T4 or higher reached 90% in the hyperbaric group
compared with 20% in the isobaric group (P = 0.005). Our results suggest that hyperbaric levobupivacaine was more predictable
for sensory block level and more eﬀective for surgical procedures with lower abdominal approach. Hyperbaric levobupivacaine
seems to be suitable, but the optimal dosage needs further investigation.
1.Introduction
An increasing number of studies compare spinal levobupiva-
caine, an S(−)-enantiomer of bupivacaine, with racemic bu-
pivacaine or other local anesthetics, either isobaric or hyper-
baric, for obstetrics, orthopedics, herniorrhaphy, and tran-
surethral surgeries [1–4]. Only one study [5] compared the
isobaric to the hyperbaric form of the same agent. How-
ever there are no conclusive data yet, whether one form is su-
perior to the other, especially in lower abdominal surgery.
Up to now there is no study about spinal anesthesia in gy-
necological surgery with abdominal incision which requires
a higher level of sensory block. Therefore the quality of an-
esthesia, sensory and motor block characteristics and hemo-
dynamics in patients requiring a higher level of spinal block
for lower abdominal approach after either hyperbaric or iso-
baric levobupivacaine are of particular interest. In addition,
anesthesiologists in our country generally use the hyperbaric
form of local anesthetics for intra-abdominal surgery but
the manufactured hyperbaric form of levobupivacaine is not
available; so it is interesting to know whether it is worth
making it hyperbaric.
T h eo b j e c t i v e so ft h i ss t u d ya r et oi n v e s t i g a t es p e c i ﬁ c
blocking characteristics, surgical quality, and side eﬀects of
intrathecal hyperbaric levobupivacaine compared with iso-
baric levobupivacaine for gynecologic surgery with abdomi-
nal incision.
2. Methods
This prospective randomized, double-blinded study was
approved by Siriraj Institutional Review Board (Si211/2006)
andregisteredwithClinicalTrials.gov(NCT01349751).Writ-
ten informed consent was obtained from 20 ASA I–III
patients, aged 18–70years, who were scheduled for elective
gynecologic surgery including total abdominal hysterecto-
my with or without uni/bilateral salpingo-oophorectomy,
uni/patientsovarian cystectomy, or myomectomy, at Siri-
raj Hospital gynecologic operating rooms. Patients with2 The Scientiﬁc World Journal
contraindications for spinal block, BMI more than 35kg/m2,
and height less than 150cm were excluded.
Under standard monitoring all patients received 15mL/
kg of lactated Ringer’s solution intravenously during the
insertionofepiduralcatheterandcompletedbeforeinducing
spinal block. Epidural catheter 16G was inserted at the L2-
3 interspace in the right lateral decubitus position, midline
approach and retained for postoperative epidural opioid
analgesia and as a rescue treatment in case of inadequate
spinalanesthesia.Preoperativelynoepiduralanestheticswere
administered.
Using a computer-generated randomization sequence
with sealed envelopes, patients were allocated to receive ei-
ther isobaric or hyperbaric levobupivacaine (Chirocaine,
Abbott Laboratories, Nycomed Pharma AS, Norway). Both
solutions were aseptically prepared immediately before in-
jection by an anesthesiologist, who was not involved in fur-
ther patient care, by adding either 0.48mL of 50% glucose
(240mg to make 8% glucose) or saline solution to 2.52mL
of 0.5% isobaric levobupivacaine (12.6mg), the only prepa-
ration of levobupivacaine we have, to achieve a ﬁnal concen-
tration of 0.42% levobupivacaine in 3mL.
After inserting an epidural catheter, we performed spinal
anesthesia to the patient in the same position on the hor-
izontal plane operating table, at L3-4 interspace, midline
approach, using a 26G Quincke spinal needle (Becton
Dickinson, Madrid, Spain). The anesthetic was injected with
approximately 0.1mL/sec. Cerebrospinal ﬂuid (CSF) was as-
pirated once at the end of the injection to conﬁrm the po-
sition of the needle. The time ﬁnishing the injection was
considered “time zero.” The patient was immediately turned
supine.
An investigator blinded to the type of solution recorded





time, and regression time to T10 level were determined.
Motor blockade, onset as well as regression, was evalu-
ated concurrently with sensory blockade, using a modiﬁed
Bromage score 0–3 (0, no motor block; 1, unable to raise
extended legs, able to move knees and feet; 2, unable to raise
extended legs and move knees, able to move feet; 3, complete
motor block of the lower limbs). We deﬁned adequate motor
block (score ≥2) and/or no response to pain as tested by the
surgeon as readiness for surgical incision.
Basic hemodynamic variables were recorded frequent-
ly. Hypotension was deﬁned as a decrease in systolic blood
pressure by ≥20% from baseline value or to <100mmHg
and was treated with a rapid IV infusion and an incre-
mental IV bolus of either ephedrine (6–12mg) if heart rate
was <100bpm or norepinephrine (4mcg) if heart rate was
≥100bpm. Bradycardia was deﬁned as heart rate <45bpm
and treated with IV atropine 0.01mg/kg.
Fifteenminutesafterspinalinjection20–30mgpethidine
and/or 1-2mg midazolam could be given intravenously, if
required. If a patient felt uncomfortable with some recurrent
pain, ketamine 10–20mg IV could be given incrementally,
additionally. Thirty minutes before the estimated end of
operation,morphine3or4mg(forpatients>60or ≤60years
old, resp.) in normal saline solution 4mL was given via epi-
duralcatheter.Allmedicationsandtimegivenwererecorded.
Surgeons were asked to rate the convenience of surgical
condition. Spinal block was considered successful when sur-
gerywascompletedwithoutconvertingtoepiduralorgeneral
anesthesia. Patients assessed the quality of anesthesia using a
grading system 0–3, sedated (0 (worst), discomfort because
of pain; 1 (poor), discomfort because of feeling intense
pressure or traction; 2 (fair), comfortable but experienced
pressure and traction; 3 (good), comfortable without any
feeling, and sedated, no grading possible). This was done 4
times whenever possible, that is, at skin incision time, 1 hour
and 2 hours after injection of levobupivacaine, and at skin
suture time.
We determined a T4 sensory block level within 10–15
minutes to estimate sample size, as T4 is adequate for intra-
abdominal surgery with peritoneal traction, and 15 minutes
is an interval suitable for clinical routine. After investigating
ten(ﬁveineachgroup)randomizedpatientsasapilotgroup,
time to T4 level in the hyperbaric group had the mean ±
SD of 9.8 ± 3.0 minutes, while two cases in the isobaric
could reach T4 level within 15 minutes, and the other three
could not reach T4 within 30 minutes. So we assumed that
the diﬀerence of 5 minutes in time to T4 level should be
considered clinically signiﬁcant. At 2-sided type I error of
0.05, 80% power, and pooled SD of 3.76, a sample size of 9.9
f o re a c hg r o u pw a sr e q u i r e dt od e t e c ta5 - m i n u t ed i ﬀerence
in time to T4 sensory block.
Diﬀerences between the groups in quantitative variables
were presented as mean and SD and statistically analyzed
usingMann-WhitneyU-test.CategoricaldataincludingASA
status, diagnosis, operative procedure, levels of sensory block
at 5 and 15 minutes, the peak levels of sensory block, the
numbers of patients requiring atropine, vasopressors, or sed-
atives, and the quality of success were analyzed using Fisher’s
exact test and presented as number and percentage. The in-
tervals to reach T4 sensory block level were compared using
Kaplan-Meier survival curve and log rank test. Using SPSS
17.0 for all statistics, we considered a P value <0.05 as
statistically signiﬁcant.
3. Results
Twenty patients were equally allocated into two groups, the
isobaric versus the hyperbaric group (Figure 1). There were
no diﬀerences with respect to age, height, weight, BMI, ASA
status as well as perioperative hemodynamics, amount of IV
ﬂuid given, and operation time (Table 1). Diagnoses (my-
oma, adenomyosis, endometriosis, and ovarian cyst) and
types of operation (total abdominal hysterectomy with or
without uni/bilateral salpingo-oophorectomy, myomectomy,
and ovarian cystectomy) were similar. No serious adverse
events happened perioperatively.
Hyperbariclevobupivacaine,comparedwithisobariclev-
obupivacaine, reached higher sensory block levels at 5 mi-
nutes (T8 versus L1, P = 0.011) and 15 minutes (T4 versus
T7, P = 0.027) after injection, and a higher peak sensoryThe Scientiﬁc World Journal 3
Analyzed (n = 10) Analyzed (n = 10)
Assess for eligibility (n = 20) at
faculty of medicine Siriraj Hospital
Group isobaric (n = 10)
0.5% levobupivacaine 2.52 mL
+NSS 0.48
Group hyperbaric (n = 10)
0.5% levobupivacaine 2.52 mL
+50% glucose 0.48 mL





Figure 1: CONSORT ﬂow diagram.
Table 1: Characteristics of patients receiving spinal anesthesia with isobaric or hyperbaric levobupivacaine for gynecologic surgery. Values
are mean ± SD [min–max] or number of patients.
Isobaric (n = 10) Hyperbaric (n = 10) P value
Age (yr) 44.8 ± 6.3 [34–55] 42.6 ± 7.3 [28–50] 0.592
Body weight (kg) 59.4 ± 8.5 [48–74] 54.9 ± 9.1 [40–69] 0.342
Height (cm) 158.1 ± 3.2 [154–165] 157.5 ± 5.6 [150–171] 0.484
BMI (kg/m2) 23.8 ± 3.7 [17.6–30.4] 22.1 ± 3.3 [16.6–27.5] 0.342
ASA class I:II (n) 8:2 8:2
Average baseline systolic BP (mmHg) 129 ± 7 [120–140] 121 ± 10 [105–134] 0.143
Average baseline diastolic BP (mmHg) 76 ± 9 [63–89] 70 ± 7 [60–79] 0.172
Average baseline heart rate (bpm) 84 ± 13 [63–106] 84 ± 17 [68–117] 0.796
Amount of IV ﬂuid in 15 minutes before levobupivacaine injection (mL) 690 ± 139 [500–850] 651 ± 126 [500–810] 0.587
Operation time (min) 94 ± 26 [51–135] 110 ± 49 [45–213] 0.684
block (T4 versus T8, P = 0.040). Number of patients
in each level of sensory block after hyperbaric compared
with isobaric levobupivacaine (Figure 2) are as follows: at
ﬁve minutes: T10 or higher, ten versus four patients (P =
0.011); at 15 minutes: T4 or higher, nine versus two patients
(P = 0.005); and at the peak sensory block: T4 or higher,
nine versus two patients (P = 0.005). In three patients
sensory spreading continued until 30 minutes (hyperbaric,
n = 2, T4 to T3 level; and isobaric, T1 to C8 level). One
patient in the isobaric group had no sensory block at all,
although she had complete motor block (Bromage score 3
at 15 minutes). After Kaplan-Meier survival curve and log
ranktest,90%ofpatientsinthehyperbaricgroupreachedT4
sensory block level within 15 minutes while only 20% in the
isobaric group did (P = 0.002) (Figure 3). As demonstrated
in Table 2 signiﬁcant diﬀerences could be identiﬁed only
in the time intervals reaching T10 level and Bromage score
1. No diﬀerence was found for the intervals between spinal
injection,andreadinessforsurgicalincision(16.6versus17.5
minutes). In patients not converted to alternative anesthesia
(nineinthehyperbaricgroupwithT4andabove,andfourin
theisobaricgroupwiththepeaklevelsatC8,T4,T5,andT6),
two-segment regression time, regression time to T10 level,
and regression time to modiﬁed Bromage score 2 (ability to
move feet) were similar. In one hyperbaric group patient,
regression time to T10 level could not be determined due




Twenty percent of patients in the isobaric and 40% in the
hyperbaric groups receivedatropine forbradycardia.Seventy
percent of patients in the isobaric and 60% in the hyperbaric
groups needed ephedrine for hypotension.
Failure of spinal anesthesia happened in six patients in
the isobaric and one in the hyperbaric group (60% versus
10%). Six patients with isobaric levobupivacaine could be
admitted to surgery, but two of them needed epidural anes-
thesia later because the sensory block levels (T7 and T10) did
not spread any further and peritoneal stimulation was not
tolerated. The other four patients needed epidural anesthesia
before starting the operation due to incomplete surgical
anesthesia. One patient in the hyperbaric group needed gen-





























































































































































































Peak levels of sensory block‡
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Figure 2:Sensoryblocklevelsat5and15minutesafterspinalblock,andpeaklevelsofsensoryblockinpatientsreceivingisobaric(bluebars)
or hyperbaric levobupivacaine (red bars). Hyperbaric levobupivacaine reached higher sensory block levels at all periods of time (∗P = 0.011,
†P = 0.027, and ‡P = 0.040, resp.). More patients in hyperbaric group reached T10 or higher at 5 minutes, T4 or higher at 15 minutes, and
higher peak levels of sensory block than in isobaric group (∗P = 0.011, †P = 0.005, and ‡P = 0.005, resp.).
Table 2:Characteristicsofintrathecalblockswithisobaricorhyperbariclevobupivacaineinpatientsundergoinggynecologicsurgery.Values
are number of patients in each group, or minutes in mean ± SD [min–max].
Isobaric: Hyperbaric (n) Isobaric (min) Hyperbaric (min) P value
Time to T10 sensory block 8:10 6.6 ± 4.7 [2–15] 2.8 ± 1.1 [1–5] 0.039
Time to T4 sensory block 2:9 10.0 ± 7.1 [5–15] 9.1 ± 3.7 [4–15]
Time to peak sensory block 9:10 13.8 ± 6.8 [8–30] 15.9 ± 8.1 [7–30] 0.517
Time to modiﬁed Bromage score 1 10:10 6.9 ± 5.3 [2–20] 2.9 ± 2.9 [1–10] 0.013
Time to modiﬁed Bromage score 3 9:10 13.6 ± 7.3 [5–30] 8.2 ± 6.8 [1–24] 0.064
Time to incision 6:10 17.5 ± 4.6 [11–25] 16.6 ± 4.9 [12–27] 0.623
2-segment regression time 4:9 98.3 ± 29.5 [60–123] 110.8 ± 42.9 [60–192]
Regression time to T10 4:8 160.0 ± 50.4 [100–222] 158.9 ± 60.0 [91–262]
Regression time to modiﬁed Bromage score 2 4:9 143.3 ± 74.7 [60–240] 102.4 ± 20.9 [70–131]
Values are compared with Mann-Whitney U-test.
anesthesia. Nine hyperbaric and four isobaric group patients
completed the operation with spinal anesthesia, but most
of them required additional systemic sedation or analgesia
(Table 3).
Thequalityofsurgicalanesthesiastartedtodeclineatone
hour after spinal injection in both groups; only two patients
with hyperbaric and one patient with isobaric levobupiva-
caine assessed the anesthetic quality as “good” (Table 4).
4. Discussion
In our study the anesthetic eﬃciency of 3mL 0.42% hyper-
baric levobupivacaine was superior to 3mL 0.42% plain lev-
obupivacaine. Patients with hyperbaric solution had a faster
onset of sensory and motor block and reached T4 sensory
levels, estimated to be suﬃcient for the planned surgical
procedures,faster,andmorereliablythanwithisobaric.Nine
patients (90%) in the hyperbaric group underwent surgery
completely without additional anesthesia compared with
four (40%) in the isobaric group. However, in both groups
the anesthetic eﬀect started fading away gradually at one
hour after spinal injection. Although surgery could be ﬁn-
ished in all of these patients with the help of additional seda-
tives or analgesics, the outcome was not satisfying.
Senetal.[5]performedspinalanesthesiawithhyperbaric
andisobariclevobupivacainenearlyinthesamemannerasin
our study, that is, dosage, concentration, and volume. They
could show that hyperbaric levobupivacaine had a faster on-
set of sensory and motor block, reaching maximum sensory
block and Bromage score 3 faster, and had a shorter duration
of sensory and motor block than did the isobaric form,
except for 2-segment regression time, which were similar in
both groups. Contrary to them, we found signiﬁcant diﬀer-
ences only in the onset of sensory and motor block (Table 2).The Scientiﬁc World Journal 5
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Figure 3: Comparison of time to T4 after isobaric (dotted line) and hyperbaric (dashed line) levobupivacaine (P = 0.002).
Table 3:Reasonsforsupplementaldrugsandconvenienceinperforminggynecologicalsurgerywithabdominalincisioninpatientsreceiving
intrathecal blocks with isobaric or hyperbaric levobupivacaine. Values are number (proportion).
Isobaric (n = 10) Hyperbaric (n = 10)
Medication for
(i) Anxiety 1 (10) 5 (50)
(ii) Inadequate analgesia 9 (90) 3 (30)
(iii) Surgical diﬃculty 1 (10)
(iv) No need 1 (10)
Convenience for surgeons
(i) Impossibility to start operation 4 (40) 0
(ii) Impossibility to continue operation 2 (20) 1 (10)
(iii) Some diﬃculty during operation 3 (30) 2 (20)
(iv) Satisfactory 1 (10) 7 (70)
However, the surgery in their study was prostatectomy with
transurethral approach, which had less exposure to pain
and needed a lower sensory block level (T10) than the level
neededforintra-abdominalgynecologicoperation(T4)asin
our study.
Solakovic [6] investigated isobaric and hyperbaric bupi-
vacaine (15mg, 0.5%) in patients with orthopedic, urologic,
and gynecologic surgery. The hyperbaric agent had a higher
peak sensory block level at T5 [T1–T7] compared with T10
[T5–L2] in the isobaric group but led to a high block with
consecutive hemodynamic instability in some patients. Xu et
al.[7]reportedpatientsundergoinglowerabdominalsurgery
who received spinal injection of either hyperbaric or isobaric
bupivacaine (15mg, 0.5%) in lateral decubitus position and
then were shifted to supine position similar to our study.
They found a higher sensory peak level and shorter time to
achieveit,ashortersensoryandmotorblockregressiontime,
a longer recovery time for urination function, and higher
incidences of side eﬀects, with the hyperbaric solution, and
concluded that isobaric bupivacaine was superior to its hy-
perbaric form. Camponovo et al. [8] compared 40mg and
60mg 2% hyperbaric with 60mg 2% plain prilocaine for
spinal anesthesia in outpatient surgery. The hyperbaric so-
lutions had faster onset times, higher peak level, shorter du-
ration of surgical block, and faster time to urination than did
the plain solution, suggesting its superiority for the ambula-
torysetting.Lucketal.[9]compared3mLof0.5%hyperbar-
ic levobupivacaine, bupivacaine, and ropivacaine for spinal
anesthesia. Levobupivacaine and bupivacaine were clinically
the same while ropivacaine had shorter duration of sensory
and motor block.
The diﬀerences in our study may partly be due to diﬀer-
ent baricity of the solutions used. Baricity is a measure of the
relative density of local anesthetic solution when compared
with CSF. According to Hocking and Wildsmith [10]l o c a l
anesthetics which have baricity which ranges from 0.9990 to6 The Scientiﬁc World Journal
Table 4: Quality of surgical anesthesia graded by patients at incision time, at 1 hour and 2 hours after injection of local anesthetic, and at
skin suture time. The intervals between skin incision and suture time in isobaric and hyperbaric groups were [min–max] [51–135] minutes
and [45–213] minutes, respectively. Values are number of patients.
Quality of surgical anesthesia
Time Group n Worst Poor Fair Good Sedated
Skin incision I∗ 71 02 4 0
H† 10 0 0 3 7 0
1 hour after injection I∗ 40 02 1 1
H† 90 24 2 1
2 hours after injection I∗ 20 11 0 0
H† 50 13 0 1
Skin suture I∗ 40 12 0 1
(time varied) H† 90 25 1 1
Worst: discomfort because of pain; Poor: discomfort, feeling intense pressure or traction; Fair: comfortable but experiencing pressure and traction; Good:
comfortable without any feeling; Sedated: no grading possible. I∗, Isobaric; H†, Hyperbaric.
1.0010 are isobaric; so 0.42% plain levobupivacaine used in
our study is considered isobaric, as both baricities of 0.25%
and 0.5% plain levobupivacaine are within these isobaric
ranges (calculated from the density of plain levobupivacaine
at 37◦Cr e p o r t e db yM c L e o d[ 11] divided by the density
of CSF at 37◦C, reported by Lui et al. [12]). Since opioids,
except pethidine, are hypobaric [12], so we avoided injecting
morphine together with levobupivacaine intrathecally but
provided epidurally later for postoperative analgesia instead.
Gori et al. [13] suggested that isobaric levobupivacaine
in CSF acts indiﬀerently to gravitational forces, both imme-
diately after the injection and later on. Therefore levels of
sensory block after intrathecal isobaric levobupivacaine are
unaﬀected by the patient position following the injection.
This might be an advantage over plain bupivacaine which
has the tendency to spread unexpectedly high even after a
reasonable time for ﬁxation [14, 15] thus causing late com-
plications such as hypotension and bradycardia from high
block. Ariyama et al. [16]r e p o r t e dd i ﬀerently to Gori’s that
the duration in the sitting position after injection, not the
baricity, aﬀected the cephalad spread of 0.5% bupivacaine,
but they used only small volumes (1mL) of 0.5% iso- and
hyperbaric bupivacaine. In our study the highest sensory
level (C8) occurred in one patient with isobaric levobupiva-
caine. As we did control the position of the patients during
and after injection, the dose of the anesthetic injected, as
well as other factors inﬂuencing the spread, that is, patients
characteristics and technique of injection, the variation of
cephalad spread could be due to baricity [2, 6, 15–18].
The minimum local anesthetic dose (MLAD) of levobu-
pivacaine is 10.58mg for Cesarean section [19] and 5.68mg
for lower limb surgery [20]. As there are no data available,
we estimated that 12.6mg would be appropriate for patients
with lower abdominal incision. Our data suggest that gy-
necological surgery with lower abdominal approach and a
mean duration of about 2 hours needs sensory blockade at
T4 level. Nine patients (90%) in the hyperbaric group could
achieve T4 level, compared with two (20%) in the isobaric
group. Nine patients (90%) in the hyperbaric group were
able to start and ﬁnish surgery with spinal anesthesia, with
some analgesics and sedatives supplement, compared with
four patients (40%) in the isobaric group. As quality of
surgical anesthesia declined after an hour independently of
the agent used, we concluded that the dosage given was too
low to provide analgesia up to T4 sensory level long time
enough. Further studies should be done to ﬁnd the optimal
dose and to ﬁnd whether a higher site of needle insertion or
a faster rate of injection with measures correlated to gravity,
for example, a head-up or head-down position, can provide
betteranesthesiaforintra-abdominalsurgery,whichrequires
a sensory block level up to T4 and may last up to three hours.
Continuous spinal anesthesia suggested by M¨ ollmann [21]
may be an interesting alternative, achieving both adequate
anesthesia and improved control of cephalad spread.
The data of our study suggest better anesthesia with hy-
perbaric levobupivacaine compared with its isobaric form in
intra-abdominal surgery that lasts not more than one hour.
The wide variation of peak sensory block levels of plain
levobupivacaine (L1 to C8) makes its eﬀect markedly less
predictablethanthatofthehyperbaricform(T7toT2).Nev-
ertheless,levobupivacainecouldbeanenrichmentwithinthe
anesthetic arena, at least in its hyperbaric form.
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